Mirum Pharmaceuticals vs Teleflex

Mirum Pharmaceuticals (MIRM), health care, and Teleflex (TFX), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

Teleflex is worth $6.3B on the stock market and Mirum Pharmaceuticals $6B: Teleflex is valued at 5% more. Mirum Pharmaceuticals's operating margin in its latest fiscal year was -4.25% and Teleflex's 5.94%. Over the past year Mirum Pharmaceuticals's share price has moved +26.9% and Teleflex's +46.2%.

Key facts

Mirum Pharmaceuticals market value
$6B
Teleflex market value
$6.3B
Teleflex P/E
78.6
Mirum Pharmaceuticals revenue
$521.3MFY to 2025-12-31
Teleflex revenue
$2BFY to 2025-12-31
Superinvestors holding both
0

Market values as of .

Mirum Pharmaceuticals vs Teleflex: every measure side by side
Measure Mirum Pharmaceuticals Teleflex
SectorHealth CareHealth Care
Country United States United States
Fiscal year ends2025-12-312025-12-31
Size
Market cap$6Blower$6.3Bhigher
Revenue$521.3Mlower$2Bhigher
Earnings-$23.4Mhigher-$905.6Mlower
Employees470lower15,500higher
Total assets$842.8Mlower$6.9Bhigher
Valuation
P/E—78.6
P/S11.5higher3.2lower
P/B—1.8
Dividend yield0.00%lower0.87%higher
Profitability
Operating margin-4.25%lower5.94%higher
Balance sheet
Net assets$314.7Mlower$3.1Bhigher
Total liabilities$528.1Mlower$3.8Bhigher
Total debt—$2.6B
Cash on hand$296.7Mlower$378.6Mhigher
Price change
Today+0.40%lower+1.56%higher
1 year+26.9%lower+46.2%higher

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

Loading the one-year price chart…

Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

Both (0)

None of the tracked investors.

Mirum Pharmaceuticals only (3)

Percentages are each holding's share of that investor's reported portfolio. Who owns MIRM · Who owns TFX

Further comparisons

Learn

Questions and answers

Which is bigger, Mirum Pharmaceuticals or Teleflex?

By market value, Teleflex is the larger: $6.3B against $6B for Mirum Pharmaceuticals. By revenue in its latest fiscal year, Teleflex is the larger: $2B against $521.3M for Mirum Pharmaceuticals.

Which has the higher operating margin?

Teleflex: 5.94%, against -4.25% for Mirum Pharmaceuticals. Operating margin is operating income as a share of revenue in the latest fiscal year.

Which has the higher dividend yield?

Teleflex: 0.87%, against 0.00% for Mirum Pharmaceuticals. Dividend yield is the last twelve months' dividends as a share of today's share price.

Which superinvestors own both Mirum Pharmaceuticals and Teleflex?

None of the tracked superinvestors holds both in their latest 13F filing. 3 hold Mirum Pharmaceuticals and 4 hold Teleflex.

Cite this page

Funkfolio, “Mirum Pharmaceuticals vs Teleflex”, data as of 18 November 2026. https://funkfolio.com/compare/mirm-vs-tfx

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.